BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2748158)

  • 1. [Management of vomiting induced by polychemotherapy in Hodgkin's disease].
    Berényi E; Kiss E
    Orv Hetil; 1989 Jun; 130(26):1383-6. PubMed ID: 2748158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in the management of chemotherapy-induced emesis].
    Murakami M; Ota K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):401-11. PubMed ID: 3006594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the clinical efficacy and safety of ondansetron and metoclopramide in the prophylaxis of emesis induced by cancer chemotherapy regimens including cisplatin.
    Advani SH; Gopal R; Dhar AK; Lal HM; Cooverji ND
    J Assoc Physicians India; 1996 Feb; 44(2):127-30. PubMed ID: 10999066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiemetic protocol in oncohematologic polychemotherapy].
    Bianconcini G; Mazzali F; Morini A; Gobbi F
    Minerva Med; 1988 May; 79(5):379-86. PubMed ID: 3374828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined use of ondansetron and other anti-emetics to control cisplatin-induced nausea and vomiting].
    Zeng WY
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):118-21. PubMed ID: 8223120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nausea and vomiting during treatment with cytostatics].
    Kaasa S; Mella O; Kvikstad A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):941-4. PubMed ID: 2042209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effectiveness of metoclopramide and dexamethasone in the prevention of cytostatic-induced vomiting].
    Usnarska-Zubkiewicz L; Kotlarek-Haus S; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Gabryś K
    Pol Tyg Lek; 1990 Aug 6-13; 45(32-33):665-8. PubMed ID: 2077509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metoclopramide, methylprednisolone and flunitrazepam in cytostatic-induced vomiting].
    Joss R; Rohrbach D; Pirovino M; Bischoff A; Kiser J; Brunner K
    Schweiz Med Wochenschr; 1987 Dec; 117(52):2113-7. PubMed ID: 3433092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients--a randomized study.
    Lehoczky O; Udvary J; Bagaméri A; Pulay T
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):94-7. PubMed ID: 15036719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on the inhibitory effect of a 5-HT3 antagonist, granisetron, for nausea and vomiting induced by chemotherapy (CHOP, VEPA, high-dose ETP) for non-Hodgkin's lymphoma].
    Sasai Y; Misawa S; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Tsuda S; Ookawara Y; Nakao M; Nakagawa H; Fujii H
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):723-9. PubMed ID: 9571970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
    Harousseau JL; Zittoun R; Bonneterre J; Hedouin M; Ouvry J
    Bull Cancer; 2000 Jun; 87(6):491-7. PubMed ID: 10903790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of antiemetic drugs.
    Jordan K; Schmoll HJ; Aapro MS
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
    Campora E; Giudici S; Merlini L; Rubagotti A; Rosso R
    Am J Clin Oncol; 1994 Dec; 17(6):522-6. PubMed ID: 7977174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.